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BACKGROUND
Children with cancer represent a unique patient population with high resource, complex healthcare needs. [1] [2] [3] [4] [5] Prior to diagnosis, these children may interact minimally with the healthcare system; upon diagnosis, their needs dramatically change. However, little research has been devoted to understanding healthcare utilization in this population. Children with cancer, often excluded from analyses in prior studies of children with medical complexity (CMC), are a novel population with healthcare utilization that warrants further study.
Children with cancer have the potential to experience a wide range of life-threatening complications from their cancer or associated Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myelogenous leukemia; CMC, children with medical complexity; CNS, central nervous system; CRG, Clinical Risk Group; ED, emergency department; FN, fever and neutropenia; PMPM, per member per month therapy. [6] [7] [8] [9] For example, fever and neutropenia (FN) is a common complication of cancer therapy that requires timely evaluation 7, [10] [11] [12] in the emergency department (ED) or outpatient center, with high rates of admission. 1, 2 Rapid access to acute care and supportive treatments received within the healthcare system are likely integral to the improved survival of this population. 13 As with other CMC, the majority of pediatric oncology care is provided at urban, tertiary care centers, but patients are spread geographically. This may lead families to seek ED care and outpatient care at local facilities that do not possess the specialty services of the insti- be enrolled on Children's Health Insurance Program that covers uninsured children in families with incomes that are modest but too high to qualify for Medicaid. 14 In some states, children with cancer may qualify for Medicaid if they meet criteria for disability or by the loss of income or resources due to the financial burden on families of children with cancer. 15, 16 Previous analyses of Medicaid data have revealed that among all children, those with medical complexity account for half of Medicaid's spending on hospital care. 17 
METHODS

Study design and setting
We performed a retrospective, cross-sectional analysis of the Truven 
Study population/identification of cases
The Clinical Risk Group (CRG) software v.1.3 (3M Health Information Systems) was used to assign each Medicaid recipient to a single, mutually exclusive CRG based on the individual's diagnoses and health services utilization over a period of time. [18] [19] [20] [21] We used the CRG classification to select the population of interest: children with cancer (CRG 8; all malignancies). We used 3 years of claims data to properly assign CRG categories. 22, 23 
Outcome and exploratory variables
The main outcomes of interest were healthcare utilization and spending. We assessed the outcomes overall and by specific health services, including ED, home health/durable medical equipment, inpatient, outpatient laboratory testing, pharmacy (outpatient only), primary care, specialty care (including all outpatient specialty care), therapy/treatment (including procedures, physical, occupational, and all outpatient therapies), mental health/substance abuse (all professional and facility claims), and dental. Of note, ED charges are included within inpatient charges for those patients admitted from the ED. Spending was the payment made by Medicaid for each health service. We evaluated healthcare spending in the following ways: overall per year, per-member-per-month (PMPM) spend (calculated by summing the specific spend of a population over a year, dividing by 12, then dividing by the number of enrollees in the population), and by specific health services. We chose to evaluate PMPM spending since not all patients in this cohort were enrolled on Medicaid for the entire 12 months evaluated. PMPM spending is a standard metric used by payors to track utilization since insurance enrollment is on monthly basis.
We assessed the types of the children's cancer using 3M's CRG Episode Disease Category (EDC) for acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), central nervous system (CNS) tumors, solid tumors (non-CNS), Hodgkin lymphoma, and nonHodgkin lymphoma. Patients with nonspecified malignancies, more than one type of cancer, or rare cancers were placed into an "Other" category. Demographic characteristics included age, gender, race/ethnicity (White, non-Hispanic; Black, non-Hispanic; Hispanic;
and Other), and eligibility type (blind/disabled, Other).
Statistical analyses
We summarized patient and encounter characteristics using frequencies and percentages. We also evaluated healthcare utilization and spending-overall and by specific health services. We then stratified the healthcare utilization analyses by type of cancer. Analyses were performed on enrollees from all 10 states in the database using SAS version 9.3 (SAS Institute, Cary, NC).
RESULTS
Study population characteristics
In 2014, there were 5,905 children with cancer identified in the 10 states participating in the Marketscan Medicaid database, which accounted for 0.2% of all patients in the dataset. CMC comprised 22.3% (N = 1,516,457) of the Medicaid population in the dataset, and therefore children with cancer were 0.3% of CMC. The mean age of the children with cancer enrolled in Medicaid was 11.2 years (Table 1) .
About 40% of the children with cancer, who were Medicaid enrollees, were eligible due to disability or blindness. Regarding types of cancer, 27.2% of children had ALL, 26.8% had a non-CNS solid tumor, 24.7% had a CNS tumor, 2.6% had AML, 1.0% had non-Hodgkin lymphoma, 0.4% had Hodgkin lymphoma, and 16.7% were categorized as "other" cancer type. We found that 31.5% of children with cancer utilized inpatient care.
Health services utilization and spending
For patients who utilized inpatient care over the 1-year studied, children with cancer had a median inpatient stay of 10 days (range 4-28). 
TA B L E 1 Demographics and characteristics of children in
Medicaid, both overall and for children with cancer to
DISCUSSION
Within this multistate Medicaid population analysis, we documented spending patterns for children with cancer. We revealed that the great- 
Limitations
There are several important limitations of this study. We included all patients enrolled on Medicaid within the dataset who had visits associated with a diagnosis of cancer, but were not able to capture the spending trajectory for these patients from the date of diagnosis through treatment. We were also not able to differentiate the reasons for inpatient hospital care or outpatient services, such as whether the visits were routine follow-up versus sick visits. Also, ED utilization may be 
CONCLUSION
In summary, children with cancer have high healthcare utilization, especially inpatient hospital care. Healthcare systems and health insurance providers, including Medicaid, could benefit from performing a more detailed analysis of children with cancer within their systems and considering novel interventions to offset inpatient hospital care costs.
Future studies that combine data from a variety of sources to obtain a complete picture of healthcare utilization, including an understanding of the geographical scope of care provided to children with cancer, combined with clinical outcomes, would be useful in determining current patterns of care delivery for this unique population and its impact on health outcomes.
